BioSig Technologies News - BSGM

Company Name	Stock Ticker Symbol	Market	Type
BioSig Technologies Inc	BSGM	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.21	-14.19%	1.27	19:46:03

Open Price	Low Price	High Price	Close Price	Prev Close
1.40	1.2601	1.46	1.32	1.48

more quote information »

Recent News

Date	Time	Source	Heading
4/04/2024	11:35	GLOBE	BioSig Engages Consulting Firm for Business Model Strategies
3/11/2024	09:00	EDGAR2	Form 8-K - Current report
3/04/2024	20:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/28/2024	09:00	EDGAR2	Form 8-K - Current report
2/20/2024	10:00	GLOBE	BioSig Announces Reduction of its Workforce
2/14/2024	15:31	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/06/2024	08:35	EDGAR2	Form 8-K - Current report
2/06/2024	08:30	GLOBE	BioSig’s PURE EP™ Platform with New Near Field Tracking..
2/02/2024	17:18	EDGAR2	Form 8-K/A - Current report: [Amend]
2/01/2024	17:25	EDGAR2	Form 8-K - Current report
1/31/2024	16:05	EDGAR2	Form 8-K - Current report
1/31/2024	11:15	GLOBE	BioSig Announces Reverse Stock Split
1/30/2024	08:52	EDGAR2	Form 8-K - Current report
1/30/2024	08:30	GLOBE	BioSig Announces Cost Reductions to Improve its Financial..
1/16/2024	16:15	EDGAR2	Form D - Notice of Exempt Offering of Securities
1/12/2024	17:28	EDGAR2	Form 8-K - Current report
1/08/2024	11:00	EDGAR2	Form 8-K - Current report
1/05/2024	16:16	EDGAR2	Form S-3/A - Registration statement under Securities Act of..
1/04/2024	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/29/2023	13:37	EDGAR2	Form DEL AM - Delaying amendment
12/28/2023	16:30	EDGAR2	Form 8-K - Current report
12/28/2023	16:05	EDGAR2	Form S-3 - Registration statement under Securities Act of..
12/22/2023	16:30	EDGAR2	Form 8-K - Current report
12/18/2023	16:36	EDGAR2	Form 8-K - Current report
12/06/2023	17:07	EDGAR2	Form 8-K - Current report
12/06/2023	14:20	GLOBE	BioSig Issues Letter to Shareholders Detailing Technology..
12/05/2023	17:29	EDGAR2	Form 8-K - Current report
12/04/2023	20:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/04/2023	19:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/01/2023	09:13	EDGAR2	Form DEF 14A - Other definitive proxy statements
11/21/2023	17:32	EDGAR2	Form PRE 14A - Other preliminary proxy statements
11/14/2023	17:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/2023	17:02	EDGAR2	Form 8-K - Current report
11/13/2023	16:30	GLOBE	BioSig Announces $2.5 Million Registered Direct Offering..
11/13/2023	08:35	EDGAR2	Form 8-K - Current report
11/09/2023	08:00	GLOBE	BioSig Announces $2.5 Million Registered Direct Offering..
11/08/2023	16:05	EDGAR2	Form 8-K - Current report
11/07/2023	08:01	EDGAR2	Form 8-K - Current report
11/07/2023	08:00	GLOBE	BioSig Appoints Global MedTech Leader Fred Hrkac as New..
11/03/2023	16:32	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
11/03/2023	16:30	EDGAR2	Form DEF 14A - Other definitive proxy statements
11/02/2023	08:00	EDGAR2	Form 8-K - Current report
11/02/2023	08:00	GLOBE	BioSig’s New PURE EP™ Subscription Model Adopted by Mayo..
11/02/2023	07:17	EDGAR2	Form 8-K - Current report
11/01/2023	08:35	EDGAR2	Form 8-K - Current report
11/01/2023	08:30	GLOBE	BioSig Adds Five New Patent Awards to 100+ Total Patent..
10/24/2023	16:30	EDGAR2	Form PRE 14A - Other preliminary proxy statements
10/16/2023	17:00	EDGAR2	Form 8-K - Current report
9/27/2023	17:01	EDGAR2	Form 8-K - Current report
9/15/2023	16:54	EDGAR2	Form 8-K - Current report